Skip to main content
. 2023 May 16;14:133. doi: 10.1186/s13287-023-03303-w

Table 1.

EMF therapeutic cases

EMF type Parameter (frequency/intensity) Cell type Effect References
EMF 15 Hz/1 mT BMSCs EMF combined with VEGF promote osteogenesis and angiogenesis [16]
EMF 15 Hz/0.3 mT BMSCs EMF combined with PCL/nHA scaffold accelerate intervertebral fusion [17]
EMF 45 Hz/1 m T, 8 h/day Saos-2 osteoblast cell line EMF combined with Fe3o4 nanoparticles promote repair of rat calvarial defect [18]
EMF 31.4 µT, 1 h/day ADSCs EMF combined with PCL/CMC scaffold promote osteogenesis [19]
PEMF 1 mT, 10 min MSCs EMF promote chondrogenic differentiation [20]
AM RF EMF 27.12 MHz, 1 h/day Breast cancer cells (tumor stem cells) EMF inhibit breast cancer brain metastasis [21]
AM RF EMF 27.12 MHz Hepatocellular carcinoma (tumor stem cells) EMF inhibit hepatocellular carcinoma proliferation and metabolism [22]
EMF 1 Hz/100 mT MC4-L2 breast cancer cells EMF lead to calcium ion overload and ROS increased, resulting in necroptosis [23]
EMF 50 Hz/4.5 mT 786-O cells ELF-EMF induce G0/G1 arrest and apoptosis in cells lines [24]

A. EMF: Electromagnetic fields. PEMF: Pulsed electromagnetic fields. AM RF EMF: Athermal radiofrequency electromagnetic fields. ELF-EMF: Extremely low frequency electromagnetic fields. B. Parameter: The unit of frequency is Hertz. The unit of intensity is Tesla. C. BMSCs: Bone mesenchymal stem cells. Saos-2 osteoblast cell line: Osteosarcoma osteoblast cell line. ADSCs: Adipose Derived Stem Cells. MSCs: Mesenchymal stem cells. 786-O cells: Human renal clear cell Carcinoma. D. PCL: Polycaprolactone. CMC: Carboxymethyl cellulose. HA: Hydroxyapatite